G. Friedman et al., Apolipoprotein E-epsilon 4 genotype predicts a poor outcome in survivors of traumatic brain injury, NEUROLOGY, 52(2), 1999, pp. 244-248
Objective: To determine the ability of apolipoprotein E (APOE) genotypes to
predict days of unconsciousness and a suboptimal functional outcome in tra
umatic brain injury (TBI) survivors. Background: TBI is known to be associa
ted with neuropsychological deficits and functional disability. Recent evid
ence indicates that APOE plays a pivotal role in CNS response to injury. Me
thods: In this prospective study the authors determined the APOE genotypes
and tested their ability to predict days of unconsciousness and functional
outcome after at least 6 months in 69 survivors of TBI. A good functional o
utcome was defined as no dysarthria, behavioral abnormalities, or dysphasia
; no severe cognitive abnormalities; and the ability to live independently.
Results: The odds ratio of more than 7 days of unconsciousness was 5.69 in
those with the APOE-epsilon 4 allele compared with those without the epsil
on 4 allele (95% CI, 1.69 to 20.0; p = 0.001). Only 1 of 27 subjects (3.7%)
with the epsilon 4 allele had a good functional outcome compared with 13 o
f 42 (31.0%) of those without the epsilon 4 allele (p = 0.006). The OR of a
suboptimal outcome (fair or unfavorable) was 13.93 for those with the epsi
lon 4 allele compared with those without the allele after controlling for a
ge and time of unconsciousness (95% CI, 1.45 to 133.97; p = 0.02). Conclusi
on: The results demonstrate a strong association between the APOE-epsilon 4
allele and a poor clinical outcome, implying genetic susceptibility to the
effect of brain injury. Additional studies of TBI patients are warranted t
o confirm their findings.